ADTHERA Trademark

Trademark Overview


On Tuesday, July 5, 2022, a trademark application was filed for ADTHERA with the United States Patent and Trademark Office. The USPTO has given the ADTHERA trademark a serial number of 97489717. The federal status of this trademark filing is REGISTERED as of Tuesday, April 23, 2024. This trademark is owned by Delin Ventures Advisors Limited. The ADTHERA trademark is filed in the Treatment & Processing of Materials Services, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Cell culture, cell therapy and gene therapy manufacturing services for others; manufacturing of advanced therapy medicinal products (ATMPs) for others; custom manufacture of therapeutic drugs, medicines, cell therapies and gene therapies for others; custom manufacture of cell culture products for others; rental and leasing of cell culture, cell therapy and gene therapy manufacturing apparatus; information, advice and consultancy in relation to all the aforesaid

Downloadable software and software applications used to deliver information and content regarding advanced therapy medicinal products (ATMPs), cell and gene therapy products and services; downloadable software and software applications for use in pharmaceutical manufacturing, drug development, and delivery of therapies to patients in the fields of advanced therapy medicinal products, cell therapy and gene therapy

Biotechnology research; design and development of pharmaceutical products in the field of biotechnology; scientific research for medical purposes in the field of cell culture, cell therapy and gene therapy; scientific research consultancy in relation to cell culture, cell therapy, and gene therapy manufacturing; development of cell culture, cell therapy and gene therapy processes for others; scientific research in the nature of conducting clinical trials for others in the field of cell culture, cell therapy and gene therapy services; scientific research in the nature of conducting clinical trials for others; pharmaceutical drug development services; rental of scientific apparatus and instruments; development of processes for cell culture, cell therapy and gene therapy pharmaceutical manufacturing; development of processes for manufacturing of advanced therapy medicinal products; design and development of scientific cell culture, cell therapy and gene therapy equipment and apparatus; de...
adthera

General Information


Serial Number97489717
Word MarkADTHERA
Filing DateTuesday, July 5, 2022
Status700 - REGISTERED
Status DateTuesday, April 23, 2024
Registration Number7362949
Registration DateTuesday, April 23, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 7, 2023

Trademark Statements


Goods and ServicesCell culture, cell therapy and gene therapy manufacturing services for others; manufacturing of advanced therapy medicinal products (ATMPs) for others; custom manufacture of therapeutic drugs, medicines, cell therapies and gene therapies for others; custom manufacture of cell culture products for others; rental and leasing of cell culture, cell therapy and gene therapy manufacturing apparatus; information, advice and consultancy in relation to all the aforesaid
Goods and ServicesDownloadable software and software applications used to deliver information and content regarding advanced therapy medicinal products (ATMPs), cell and gene therapy products and services; downloadable software and software applications for use in pharmaceutical manufacturing, drug development, and delivery of therapies to patients in the fields of advanced therapy medicinal products, cell therapy and gene therapy
Goods and ServicesBiotechnology research; design and development of pharmaceutical products in the field of biotechnology; scientific research for medical purposes in the field of cell culture, cell therapy and gene therapy; scientific research consultancy in relation to cell culture, cell therapy, and gene therapy manufacturing; development of cell culture, cell therapy and gene therapy processes for others; scientific research in the nature of conducting clinical trials for others in the field of cell culture, cell therapy and gene therapy services; scientific research in the nature of conducting clinical trials for others; pharmaceutical drug development services; rental of scientific apparatus and instruments; development of processes for cell culture, cell therapy and gene therapy pharmaceutical manufacturing; development of processes for manufacturing of advanced therapy medicinal products; design and development of scientific cell culture, cell therapy and gene therapy equipment and apparatus; design and development of scientific advanced therapy medicinal products, pharmaceutical manufacturing equipment and apparatus; software as a service (SaaS) featuring software for pharmaceutical manufacturing and drug development in the field of advanced therapy medicinal products, cell therapy, gene therapy and cell culture; providing temporary use of, online non-downloadable software and online non-downloadable software platforms for pharmaceutical manufacturing and drug development in the field of advanced therapy medicinal products, cell therapy, gene therapy and cell culture; software as a service (SaaS) featuring software for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; platform as a service featuring computer software platforms for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; providing temporary use of online non-downloadable software and online non-downloadable software platforms for reviewing, purchasing, ordering, tracking, delivering, monitoring and analysing advanced therapy medicinal products, cell therapy, gene therapy and cell culture products and services; providing information, advice and consultancy in relation to all the aforesaid

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code040
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code009
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 25, 2022
Primary Code042
First Use Anywhere DateThursday, January 1, 1970
First Use In Commerce DateThursday, January 1, 1970

Trademark Owner History


Party NameADTHERA BIO LIMITED
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressLONDON, GB WC2B 5LT

Party NameADTHERA BIO LIMITED
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressLONDON, GB WC2B 5LT

Party NameADTHERA BIO LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type24 - NOT AVAILABLE
AddressLONDON, GB WC2B 5LT

Party NameDelin Ventures Advisors Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon, GB WC2B5LT

Trademark Events


Event DateEvent Description
Friday, July 8, 2022NEW APPLICATION ENTERED
Friday, July 8, 2022TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, July 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 15, 2022ASSIGNED TO LIE
Monday, August 15, 2022PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, April 18, 2023ASSIGNED TO EXAMINER
Tuesday, May 2, 2023NON-FINAL ACTION WRITTEN
Tuesday, May 2, 2023NON-FINAL ACTION E-MAILED
Tuesday, May 2, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 9, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, August 30, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 30, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, August 30, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, August 30, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, September 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 3, 2023ELECTRONIC RECORD REVIEW COMPLETE
Friday, September 29, 2023ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, November 7, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 18, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 5, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, March 17, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, April 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED